Human Umbilical Vein Endothelial Cells Aptamer Details
ID# 7645
Structure
Chemistry
Peptide
Target
Human Umbilical Vein Endothelial Cells
Category
Cells
Affinity (Kd)
N/A nM
Length
5
Aptazyme
No
Sequence (3-char table code)
G
A
C
U/T
NH2-CysGlyLysArgLys-COOH
Molecular Weight: 600.85
Extinction Coefficient:
Binding Conditions / Buffer
Binding Temp:
Refolding Protocol
If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Reference
Agemy et al. "Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma." PNAS, doi: 10.1073/pnas.1114518108.
Request a Quote
Have your aptamer oligo synthesized by Aptagen.
